Astal Laboratories allots 14.7 lakh shares at ₹40 each

Astal Laboratories Limited has announced the allotment of 14,70,000 equity shares upon the conversion of warrants by persons belonging to the non-promoter category. The decision was approved by the Board of Directors during a meeting held on May 12, 2026, at the company's corporate office in Telangana.

The equity shares have been issued at a price of ₹40 each, which includes a face value of ₹10 and a premium of ₹30 per share. The company received the remaining 75% of the issue price, totaling ₹4,41,00,000, upon the conversion of these warrants. The warrants were originally allotted on a preferential basis on November 27, 2024.

Allotment Details

The preferential issue was made to 11 strategic investors classified as non-promoters. The allotment was conducted following a special resolution passed by shareholders at the Annual General Meeting held on August 5, 2024, and subsequent in-principle approval from BSE Limited.

Sr. No. Name of the Allottees No. of Equity Shares allotted 1. DORADLA RANGA RAO 60,000 2. VENKATA KASI ANURADHA YAKKALA 240,000 3. SANKU DURGA SREE 20,000 4. PRASUNAMBA KUCHIMANCHI 70,000 5. RUKMINI PRABHA NAMBURI 50,000 6. JNV SURESH KUMAR 230,000 7. SRI HARSHA SOMA 50,000 8. SOMA SWATI 150,000 9. E VENKATACHALAM PRASAD 400,000 10. KOPURI VIJAYA KUMAR GUPTA 100,000 11. PALETH SHREE KUMAR MENON 100,000

Capital Structure Update

Consequent to this allotment, the paid-up equity capital of astal laboratories has increased. The capital has risen from ₹42,21,56,320, consisting of 42,21,56,320 equity shares of ₹10 each, to ₹43,68,56,320, consisting of 43,68,56,320 equity shares of ₹10 each.

Astal Laboratories Limited has completed its quarterly regulatory compliance by submitting the required certificate under SEBI (Depositories and Participants) Regulation 2018 for the quarter ended March 31, 2026. The pharmaceutical company, formerly known as Macro International Limited, filed the mandatory documentation with BSE Limited on April 9, 2026.

Regulatory Compliance Details

The submission pertains to Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018, which mandates quarterly reporting by registrar and share transfer agents. The certificate was prepared and issued by BEETAL Financial & Computer Services (P) Ltd, the company's appointed registrar and share transfer agent.

Parameter: Details Quarter Period: March 31, 2026 Regulation: SEBI (Depositories and Participants) Regulation 74(5) Filing Date: April 9, 2026 Registrar: BEETAL Financial & Computer Services (P) Ltd BSE Scrip Code: 512600 Security ID: ASTALLTD

Certificate Confirmation

BEETAL Financial & Computer Services confirmed that all securities received from depository participants for dematerialization during the quarter ended March 2026 were properly processed and confirmed to the depositories. The registrar verified that:

Securities received for dematerialization were confirmed (accepted/rejected) to depositories

Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed

Security certificates received for dematerialization were mutilated and cancelled after due verification

Depository names were substituted in the register of members as registered owners within 15 days

Company Information

Astal Laboratories Limited operates with its registered office in Noida, Uttar Pradesh, and corporate office in Gachibowli, Telangana. The company secretary and compliance officer Mahendra Kumar digitally signed the submission document, ensuring proper authorization and compliance with regulatory requirements.

SEBI Regulatory Framework

The certificate submission aligns with SEBI circulars including NSDL/CIR/II/5/2019 dated January 25, 2019, CDSL/OPS/RTA/POLCY/2019/14 dated January 25, 2019, and SEBI letter ref no.MRD/DOP2/DSA2/OW/2019/2498/1 dated January 24, 2019. These guidelines ensure proper handling of dematerialized securities and maintain transparency in depositories operations.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.